Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Directorate Change

27 May 2008 16:00

RNS Number : 3276V
W.H. Ireland Group PLC
27 May 2008
 



WH Ireland Group plc

("WH Ireland" or the "Company")

Appointment of Non-Executive Director

Further to the announcement on 14 May 2008 and following receipt of approvals from the FSA, WH Ireland is pleased to announce the appointment of Roland Rudd as a Non-Executive Director with effect from 27 May 2008.

Roland Dacre Rudd, aged 47 years, is co-founder and Senior Partner of Finsbury Limited and Non-Executive Director of Breakingviews Limited. Roland is the founding Chairman of Business for New Europe, the Chairman of NSPCC's Stop Organised Abuse, Chairman of the Tate's Corporate Advisory Body and on the Board of the Royal Opera House Development Committee.

Roland is also a Director of Finsbury.com Limited, Ingenious Games LLP, Millfield Foundation and Policy Network and Communications Limited. Formerly Roland was a board member of Britain in Europe and Managing Editor (Business) of The Sunday Correspondent.

As at the date of this announcement, Roland holds 485,713 ordinary shares of 5 pence each in the Company.

There is no further information to be disclosed under Schedule 2(g) of the AIM rules.

For further information, please contact:-

Rupert Lowe

Zoe Biddick

WH Ireland Group plc

Biddicks

0161 819 8750

020 7448 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABSGDULGDGGIR
Date   Source Headline
17th Nov 202512:58 pmRNSForm 8.3 - W.H. Ireland Group PLC
14th Nov 202510:13 amRNSForm 8 (DD)
13th Nov 20259:39 amRNSForm 8.3 - WH Ireland Group plc
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
5th Nov 20257:00 amRNSDirectorate Change
29th Oct 20257:00 amRNSDeferred Consideration re Capital Markets Division
27th Oct 20252:51 pmRNSResult of GM
27th Oct 20257:00 amRNSDirectorate Change
20th Oct 20251:49 pmRNSAdjournment of GM
16th Oct 20259:24 amRNSHolding(s) in Company
16th Oct 20259:23 amRNSHolding(s) in Company
9th Oct 20253:07 pmRNSResult of General Meeting
8th Oct 202510:21 amRNSResponse to Press Speculation
30th Sep 20253:23 pmRNSResult of AGM
26th Sep 20254:14 pmRNSFinal Results, Notice of GM and Annual Report
22nd Sep 20257:26 amRNSConditional disposal of Wealth Management Business
5th Sep 20257:00 amRNSNotice of AGM
10th Feb 20257:00 amRNSHenley Office
17th Dec 20241:17 pmRNSHolding(s) in Company
13th Dec 20247:04 amRNSInterim Results
17th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSNominated Adviser Status
30th Sep 20244:08 pmRNSResult of AGM
10th Sep 20249:51 amRNSHolding(s) in Company
30th Aug 202412:00 pmRNSNotice of AGM and Publication of Annual Report
22nd Aug 20245:46 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSCompletion of Sale of the Capital Markets Division
27th Jun 20246:19 pmRNSHolding(s) in Company
27th Jun 20246:17 pmRNSHolding(s) in Company
26th Jun 202410:26 amRNSConfirmation of Chair Appointment
21st Jun 20248:09 amRNSDirector Notification
3rd Jun 20247:00 amRNSSale of Capital Markets Division & Trading Update
20th May 202411:14 amRNSResponse to Press Speculation
27th Dec 20237:00 amRNSInterim Results for Six Months ended 30 Sep 2023
16th Nov 20237:00 amRNSBoard Changes
24th Oct 20232:07 pmRNSResult of AGM
27th Sep 20237:00 amRNSFinal Results and Notice of AGM
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 202310:08 amRNSHolding(s) in Company
22nd Aug 202310:07 amRNSHolding(s) in Company
21st Aug 20239:26 amRNSHolding(s) in Company
18th Aug 202311:06 amRNSHolding(s) in Company
17th Aug 20235:14 pmRNSHolding(s) in Company
17th Aug 20234:09 pmRNSHolding(s) in Company
17th Aug 20239:16 amRNSHolding(s) in Company
16th Aug 20232:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.